Polish Enterprise Fund VII, fund of Enterprise Investors reached an agreement to acquire Center for Cancer Diagnostics and Therapy from Voxel S.A. (WSE:VOX) for PLN 11 million on September 21, 2012. Enterprise Investors already made an upfront payment of PLN 5 million, with the remainder payable at a later date, subject to certain conditions. Enterprise Investors will finance the development of the radiotherapy center in cooperation with a private company and a medical university.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
95.4 PLN | +1.27% |
|
+0.21% | +21.37% |
May. 27 | Voxel S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 11 | Amadeus IT Group Buys Voxel Media in EUR113 Million Deal | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.37% | 253M | |
-18.64% | 8.46B | |
+71.50% | 4.41B | |
+11.92% | 2.88B | |
-2.80% | 2.64B | |
-16.07% | 1.73B | |
-57.49% | 1.7B | |
-16.46% | 1.5B | |
-49.06% | 1.03B | |
+16.62% | 968M |
- Stock Market
- Equities
- VOX Stock
- News Voxel S.A.
- Polish Enterprise Fund VII, fund of Enterprise Investors reached an agreement to acquire Center for Cancer Diagnostics and Therapy from Voxel S.A. for PLN 11 million.